Published in Cancer Epidemiol Biomarkers Prev on March 05, 2013
How to make more published research true. PLoS Med (2014) 2.55
Tackling NCD in LMIC: Achievements and Lessons Learned From the NHLBI-UnitedHealth Global Health Centers of Excellence Program. Glob Heart (2016) 2.39
Evolution of the "drivers" of translational cancer epidemiology: analysis of funded grants and the literature. Am J Epidemiol (2015) 2.04
Data harmonization and federated analysis of population-based studies: the BioSHaRE project. Emerg Themes Epidemiol (2013) 1.76
The next generation of large-scale epidemiologic research: implications for training cancer epidemiologists. Am J Epidemiol (2014) 1.73
Impact of National Heart, Lung, and Blood Institute-Supported Cardiovascular Epidemiology Research, 1998 to 2012. Circulation (2015) 1.42
Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology. Oncogene (2013) 1.23
Applications of electronic health information in public health: uses, opportunities & barriers. EGEMS (Wash DC) (2013) 1.18
Commentary: Epidemiology in the era of big data. Epidemiology (2015) 1.18
A new source of data for public health surveillance: Facebook likes. J Med Internet Res (2015) 1.01
The impact of neighborhood social and built environment factors across the cancer continuum: Current research, methodological considerations, and future directions. Cancer (2015) 0.98
Charting a future for epidemiologic training. Ann Epidemiol (2015) 0.97
Toward a Literature-Driven Definition of Big Data in Healthcare. Biomed Res Int (2015) 0.92
Cultivating cohort studies for observational translational research. Cancer Epidemiol Biomarkers Prev (2013) 0.90
Public Health and Epidemiology Informatics: Recent Research and Trends in the United States. Yearb Med Inform (2015) 0.89
Machine-learning prediction of cancer survival: a retrospective study using electronic administrative records and a cancer registry. BMJ Open (2014) 0.87
Genetic susceptibility in childhood acute leukaemias: a systematic review. Ecancermedicalscience (2015) 0.85
Scalable combinatorial tools for health disparities research. Int J Environ Res Public Health (2014) 0.82
The Cancer Genomics and Epidemiology Navigator: An NCI online tool to enhance cancer epidemiology research. Cancer Epidemiol Biomarkers Prev (2014) 0.81
A primer series on -omic technologies for the practice of epidemiology. Am J Epidemiol (2014) 0.81
Characterising the epigenome as a key component of the fetal exposome in evaluating in utero exposures and childhood cancer risk. Mutagenesis (2015) 0.80
Representativeness of breast cancer cases in an integrated health care delivery system. BMC Cancer (2015) 0.80
The Future of Cardiovascular Epidemiology. Circulation (2016) 0.78
Digital Connectedness in the Framingham Heart Study. J Am Heart Assoc (2016) 0.78
Quantification of population benefit in evaluation of biomarkers: practical implications for disease detection and prevention. BMC Med Inform Decis Mak (2014) 0.77
Roger et al. respond to "future of population studies". Am J Epidemiol (2015) 0.76
Trends in published meta-analyses in cancer research, 2008-2013. Cancer Causes Control (2016) 0.75
Public health: Cardiovascular disease insights--something new out of Africa. Nat Rev Cardiol (2013) 0.75
A novel web informatics approach for automated surveillance of cancer mortality trends. J Biomed Inform (2016) 0.75
The Cancer Epidemiology Descriptive Cohort Database: A Tool to Support Population-Based Interdisciplinary Research. Cancer Epidemiol Biomarkers Prev (2016) 0.75
Geospatial Approaches to Cancer Control and Population Sciences. Cancer Epidemiol Biomarkers Prev (2017) 0.75
Toward a Modern Science of Obesity at Washington University: How We Do It and What is the Payoff? Cancer Prev Res (Phila) (2016) 0.75
The basic science that is epidemiology. JACC Cardiovasc Imaging (2014) 0.75
Transdisciplinary approaches enhance the production of translational knowledge. Transl Res (2016) 0.75
Repeat: a framework to assess empirical reproducibility in biomedical research. BMC Med Res Methodol (2017) 0.75
Efficient design of clinical trials and epidemiological research: is it possible? Nat Rev Cardiol (2017) 0.75
Incorporating Data Citation in a Biomedical Repository: An Implementation Use Case. AMIA Jt Summits Transl Sci Proc (2017) 0.75
Comprehensive molecular portraits of human breast tumours. Nature (2012) 47.39
Why most published research findings are false. PLoS Med (2005) 41.68
Comprehensive genomic characterization of squamous cell lung cancers. Nature (2012) 18.90
Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One (2008) 13.32
Prepublication data sharing. Nature (2009) 12.24
21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med (2013) 7.77
Data sharing by scientists: practices and perceptions. PLoS One (2011) 6.48
Epidemiology. Environment and disease risks. Science (2010) 4.64
Public availability of published research data in high-impact journals. PLoS One (2011) 4.41
The emergence of translational epidemiology: from scientific discovery to population health impact. Am J Epidemiol (2010) 4.04
New models for large prospective studies: is there a better way? Am J Epidemiol (2012) 3.85
What makes UK Biobank special? Lancet (2012) 3.72
Moving the science of team science forward: collaboration and creativity. Am J Prev Med (2008) 3.40
The basics of translation. Science (2013) 3.00
Improving validation practices in "omics" research. Science (2011) 2.73
Tools for innovative thinking in epidemiology. Am J Epidemiol (2012) 2.48
Causal thinking and complex system approaches in epidemiology. Int J Epidemiol (2009) 2.47
Quality, quantity and harmony: the DataSHaPER approach to integrating data across bioclinical studies. Int J Epidemiol (2010) 2.44
The tension between data sharing and the protection of privacy in genomics research. Annu Rev Genomics Hum Genet (2012) 2.24
The making of ENCODE: Lessons for big-data projects. Nature (2012) 2.04
"Drivers" of translational cancer epidemiology in the 21st century: needs and opportunities. Cancer Epidemiol Biomarkers Prev (2013) 1.72
Time for a creative transformation of epidemiology in the United States. JAMA (2012) 1.70
Implementing personalized medicine in a cancer center. Cancer J (2011) 1.69
Toward a roadmap in global biobanking for health. Eur J Hum Genet (2012) 1.65
The importance of potential studies that have not existed and registration of observational data sets. JAMA (2012) 1.34
Why data-sharing policies matter. Proc Natl Acad Sci U S A (2009) 1.31
Bridging the gap between biologic, individual, and macroenvironmental factors in cancer: a multilevel approach. Cancer Epidemiol Biomarkers Prev (2013) 1.22
Point: is there a future for innovative epidemiology? Am J Epidemiol (2013) 1.21
Knowledge integration in cancer: current landscape and future prospects. Cancer Epidemiol Biomarkers Prev (2012) 1.19
Integrative cancer epidemiology--the next generation. Cancer Discov (2012) 1.16
U.S. science policy. Agencies rally to tackle big data. Science (2012) 1.16
Knowledge integration: conceptualizing communications in cancer control systems. Patient Educ Couns (2008) 1.09
Collaborations in population-based health research: the 17th annual HMO Research Network Conference, March 23-25, 2011, Boston, Massachusetts, USA. Clin Med Res (2011) 1.08
Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational research. J Natl Cancer Inst (2012) 1.04
Diving through the "-omics": the case for deep phenotyping and systems epidemiology. OMICS (2012) 1.03
Landmarks in the history of cancer epidemiology. Cancer Res (2009) 0.98
Frontiers in cancer epidemiology: a challenge to the research community from the Epidemiology and Genomics Research Program at the National Cancer Institute. Cancer Epidemiol Biomarkers Prev (2012) 0.97
Opportunities and challenges for selected emerging technologies in cancer epidemiology: mitochondrial, epigenomic, metabolomic, and telomerase profiling. Cancer Epidemiol Biomarkers Prev (2012) 0.94
Lessons from genome-wide association studies for epidemiology. Epidemiology (2012) 0.91
Cultivating cohort studies for observational translational research. Cancer Epidemiol Biomarkers Prev (2013) 0.90
Epidemiology: key to translational, team, and transdisciplinary science. Ann Epidemiol (2008) 0.90
Epidemiology in the 21st century: calculation, communication, and intervention. Am J Public Health (1999) 0.88
Cervical cytology biobanks as a resource for molecular epidemiology. Methods Mol Biol (2011) 0.87
Moving forward in human cancer risk assessment. Environ Health Perspect (2010) 0.81
Epidemiology: a problem-solving journey. Am J Epidemiol (2008) 0.80
Provocative questions in cancer epidemiology in a time of scientific innovation and budgetary constraints. Cancer Epidemiol Biomarkers Prev (2013) 0.80
Transforming health care through cloud computing. Health Care Law Mon (2012) 0.79
Finding the missing heritability of complex diseases. Nature (2009) 67.95
Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet (2008) 30.94
Somatic mutations affect key pathways in lung adenocarcinoma. Nature (2008) 30.02
Genome-wide association study identifies novel breast cancer susceptibility loci. Nature (2007) 29.23
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet (2007) 22.96
Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet (2008) 22.35
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (2009) 22.18
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med (2009) 21.74
Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet (2007) 21.18
Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature (2010) 20.01
Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet (2008) 17.65
A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med (2005) 17.32
Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet (2010) 16.96
Characterizing the cancer genome in lung adenocarcinoma. Nature (2007) 16.48
Identification of ten loci associated with height highlights new biological pathways in human growth. Nat Genet (2008) 16.25
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med (2002) 16.23
Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet (2008) 16.17
Replicating genotype-phenotype associations. Nature (2007) 16.11
Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet (2008) 15.94
Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA (2007) 15.32
Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst (2004) 14.97
Power failure: why small sample size undermines the reliability of neuroscience. Nat Rev Neurosci (2013) 13.37
Body-mass index and mortality among 1.46 million white adults. N Engl J Med (2010) 13.34
Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One (2008) 13.32
Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation (2010) 13.28
Statistics in medicine--reporting of subgroup analyses in clinical trials. N Engl J Med (2007) 12.55
Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med (2005) 12.46
The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics (2006) 12.45
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med (2009) 12.16
Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA (2005) 12.09
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol (2009) 11.80
Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet (2012) 11.09
Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med (2014) 11.07
Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol (2007) 10.49
Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet (2009) 10.34
Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat Genet (2007) 9.88
Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA (2007) 9.68
Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA (2011) 9.13
Estimation of effect size distribution from genome-wide association studies and implications for future discoveries. Nat Genet (2010) 9.07
Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA (2005) 9.03
Trust and sources of health information: the impact of the Internet and its implications for health care providers: findings from the first Health Information National Trends Survey. Arch Intern Med (2005) 8.96
Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA (2010) 8.93
Incidental meniscal findings on knee MRI in middle-aged and elderly persons. N Engl J Med (2008) 8.40
A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet (2009) 8.39
Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood (2005) 8.37
Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA (2008) 8.32
The case of the misleading funnel plot. BMJ (2006) 8.26
Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet (2013) 8.24
Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med (2002) 8.09
Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet (2010) 7.94
50-year trends in smoking-related mortality in the United States. N Engl J Med (2013) 7.80
Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet (2008) 7.65
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2010) 7.54
Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. N Engl J Med (2012) 7.47
Retracted Genomic signatures to guide the use of chemotherapeutics. Nat Med (2006) 7.45
Shifting paradigm of association studies: value of rare single-nucleotide polymorphisms. Am J Hum Genet (2008) 7.36
Genetic risk prediction--are we there yet? N Engl J Med (2009) 7.30
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet (2009) 7.30
Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ (2014) 7.21
Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. N Engl J Med (2005) 7.09
C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation (2003) 6.99
Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance. Am J Clin Nutr (2002) 6.96
Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Mod Pathol (2006) 6.86
Benign breast disease and the risk of breast cancer. N Engl J Med (2005) 6.84
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ (2011) 6.80
Ethical and practical guidelines for reporting genetic research results to study participants: updated guidelines from a National Heart, Lung, and Blood Institute working group. Circ Cardiovasc Genet (2010) 6.74
Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet (2008) 6.71
Retracted A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med (2006) 6.69
Powerful SNP-set analysis for case-control genome-wide association studies. Am J Hum Genet (2010) 6.60
Reporting participation in epidemiologic studies: a survey of practice. Am J Epidemiol (2005) 6.52
Epidemiologic evaluation of measurement data in the presence of detection limits. Environ Health Perspect (2004) 6.43
Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med (2004) 6.42
CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut (2008) 6.26
Genetic variation and cancer: improving the environment for publication of association studies. Cancer Epidemiol Biomarkers Prev (2004) 6.24
The Health Information National Trends Survey (HINTS): development, design, and dissemination. J Health Commun (2004) 6.24
Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet (2008) 6.22
Migraine and risk of cardiovascular disease in women. JAMA (2006) 6.16
Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med (2009) 6.16